αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors
Clinical trial NCT05373147 · UNKNOWN
Trial details
- NCT number
- NCT05373147
- Sponsor
- Shanghai Mengchao Cancer Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2023-02-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.